The potential ABCB1 predominance among the AML-expressed ABC transporters was further supported by significant correlation between ABCB1 inhibition by CDKI and ABCB1 expression, while no such relationship was determined for ABCG2. Here, ABCG2 is linked to acute myeloid leukemia.